CoffeeProt also identified rs2228467 as a trans-pQTL associated to eosinophil counts and Eotaxin (CCL11), a chemokine targeted by the monoclonal antibody Bertilimumab approved for the treatment of bullous pemphigoid in patients with eosinophilia. Here, CCL11 is linked to bullous pemphigoid.